DRKS00008185已完成不适用
on-interventional study to evaluate neurotoxicity under therapy with Paclitaxel Omnicare for patients with various tumor entities - NEPA
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 83
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. Male and female patients = 18 years
- •2. Diagnosis of tumor disease for which a chemotherapy with Paclitaxel Omnicare is indicated
- •3. Investigator's decision (independent of study participation) to treat the patient with Paclitaxel Omnicare®
- •4. Sufficient patient's compliance upon investigator's assessment
- •5. Written informed consent of the patient to retrospective and prospective pseudonomized documentation, to forwarding and analysis of the data and to access to the data within monitoring
排除标准
- 未提供
研究者
相似试验
已完成
不适用
on-interventional study to evaluate neurotoxicity under therapy with Docetaxel Omnicare for patients with various tumor entitiesC50C34C61C44C16Malignant neoplasm of breastMalignant neoplasm of bronchus and lungMalignant neoplasm of prostateOther malignant neoplasms of skinMalignant neoplasm of stomachDRKS00008183OMNICARE Pharma GmbH109
进行中（未招募）
1 期
Klinische Studie zur Überprüfung der Auswirkungen einer präoperativen Verabreichung von Glutamin und/oder Omega-3-Fettsäuren auf das Inflammationsgeschehen nach aortokoronaren Bypassoperationen - Inflammation-Bypassoperation-StudieIndikationsstellung für eine aortokoronare BypassoperationEUCTR2008-003971-30-ATniv.-Prof. Dr. Karlheinz Tscheliessnigg
已完成
3 期
A clinical trial to study the effect of two different radiotherapy treatment techniques in patients with cancer cervixCTRI/2018/05/014021POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH80
尚未招募
3 期
A Prospective randomized study to compare haematological toxicities and response between two different chemotherapy regimens in chemoradiotherapy treatment of carcinoma of uterine cervix.CTRI/2024/08/072198SRI VENKATESHWARA INSTITUTE OF MEDICAL SCIENCES
进行中（未招募）
1 期
The evaluation of safety and biological effects of cancer-killing virus vaccine given to patients with advanced brain tumoursMalignant neoplasm of brain, high-grade brain tumourMalignant neoplasm of brainCancerISRCTN51762486niversity of Leeds12